Hypofractionated Regimen Safe, Feasible in Elderly Bladder Cancer Patients
November 8th 2017In this interview we discuss results of the HYBRID trial, which tested a hypofractionated regimen of 36 Gy over six fractions in elderly muscle-invasive bladder cancer patients who were ineligible for standard treatments.